Mometason Sandoz (Mometasone Furoate)

Mometasone furoate is a glucocorticoid receptor agonist. After binding to receptors in nasal mucosal cells, it alters gene transcription to suppress inflammatory cytokine production, reduces vascular permeability, and limits immune cell activation, thereby decreasing nasal inflammation and associated symptoms.

The specific dose and dosing schedule of Mometason Sandoz are determined by the prescribing clinician based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the prescriber’s instructions and the product label.

Safety data for Mometason Sandoz in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order Mometason Sandoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Mometason Sandoz contains mometasone furoate, a potent nasal corticosteroid with high local anti‑inflammatory activity and minimal systemic absorption. Compared with older agents such as beclomethasone or fluticasone, it often provides effective symptom control at lower daily doses, though individual response may vary.

Mometason Sandoz should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, heat sources, and direct sunlight to maintain its stability and efficacy.

Mometason Sandoz is administered as a nasal spray. The patient should gently blow the nose, insert the spray tip into one nostril, close the opposite nostril, and spray the prescribed number of actuations while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks, though rare, include adrenal suppression, severe allergic reactions (anaphylaxis), fungal infections of the nasal passages, and significant nosebleeds. Patients should seek immediate medical attention if they experience symptoms such as unexplained fatigue, severe bleeding, or signs of an allergic reaction.

Mometason Sandoz should not be used by individuals with a known hypersensitivity to mometasone furoate or any component of the formulation. It is also contraindicated in patients with active untreated nasal infections until the infection has been resolved.